Torrent Cash And Short Term Investments vs Non Current Assets Total Analysis

TORNTPHARM

3,224 1.10 0.03%

Torrent Pharmaceuticals financial indicator trend analysis is much more than just breaking down Torrent Pharmaceuticals prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Torrent Pharmaceuticals is a good investment. Please check the relationship between Torrent Pharmaceuticals Cash And Short Term Investments and its Non Current Assets Total accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Torrent Pharmaceuticals Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Cash And Short Term Investments vs Non Current Assets Total

Cash And Short Term Investments vs Non Current Assets Total Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Torrent Pharmaceuticals Cash And Short Term Investments account and Non Current Assets Total. At this time, the significance of the direction appears to have very week relationship.

The correlation between Torrent Pharmaceuticals' Cash And Short Term Investments and Non Current Assets Total is 0.24. Overlapping area represents the amount of variation of Cash And Short Term Investments that can explain the historical movement of Non Current Assets Total in the same time period over historical financial statements of Torrent Pharmaceuticals Limited, assuming nothing else is changed. The correlation between historical values of Torrent Pharmaceuticals' Cash And Short Term Investments and Non Current Assets Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash And Short Term Investments of Torrent Pharmaceuticals Limited are associated (or correlated) with its Non Current Assets Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Assets Total has no effect on the direction of Cash And Short Term Investments i.e., Torrent Pharmaceuticals' Cash And Short Term Investments and Non Current Assets Total go up and down completely randomly.

Correlation Coefficient

0.24

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of Torrent Pharmaceuticals balance sheet. This account contains Torrent Pharmaceuticals investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Torrent Pharmaceuticals Limited fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.

Non Current Assets Total

The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.

Most indicators from Torrent Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Torrent Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Torrent Pharmaceuticals Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

The current Selling General Administrative is estimated to decrease to about 4.4 B. The current Tax Provision is estimated to decrease to about 4.1 B

	2021	2022	2023	2024 (projected)
Interest Expense	2.5B	3.3B	3.5B	1.8B
Depreciation And Amortization	6.6B	7.0B	8.0B	8.4B

Interest Expense Depreciation And Amortization

Torrent Pharmaceuticals fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Accounts Payable	Short Term Investments	Intangible Assets	Current Deferred Revenue	Short Term Debt
Total Assets		0.94	0.66	0.99	0.84	0.98	0.92	0.67	0.18	0.91	0.22	0.4	0.87	0.2	0.93	0.95	0.45	-0.21	0.98	0.93	0.59	0.85	0.28	0.96	0.02	0.88
Short Long Term Debt Total	0.94		0.62	0.95	0.72	0.9	0.99	0.52	0.04	0.89	0.14	0.3	0.77	0.04	0.97	0.85	0.42	-0.31	0.98	0.81	0.44	0.77	0.26	0.97	-0.04	0.91
Other Current Liab	0.66	0.62		0.65	0.53	0.68	0.6	0.33	0.23	0.58	0.28	0.38	0.54	0.22	0.66	0.68	0.57	-0.06	0.67	0.68	0.14	0.7	0.24	0.57	-0.14	0.47
Total Current Liabilities	0.99	0.95	0.65		0.81	0.97	0.92	0.65	0.26	0.9	0.17	0.37	0.87	0.2	0.92	0.94	0.43	-0.19	0.99	0.91	0.58	0.85	0.21	0.96	-0.05	0.9
Total Stockholder Equity	0.84	0.72	0.53	0.81		0.86	0.7	0.94	0.15	0.94	0.3	0.27	0.72	0.53	0.7	0.85	0.36	0.15	0.78	0.79	0.83	0.68	0.13	0.81	0.03	0.8
Property Plant And Equipment Net	0.98	0.9	0.68	0.97	0.86		0.87	0.7	0.24	0.9	0.12	0.31	0.85	0.21	0.87	0.98	0.48	-0.21	0.95	0.91	0.57	0.81	0.17	0.92	-0.04	0.88
Net Debt	0.92	0.99	0.6	0.92	0.7	0.87		0.49	-0.06	0.88	0.16	0.28	0.73	0.01	0.97	0.83	0.43	-0.35	0.96	0.78	0.41	0.73	0.3	0.96	-0.01	0.89
Retained Earnings	0.67	0.52	0.33	0.65	0.94	0.7	0.49		0.24	0.83	0.18	0.1	0.59	0.67	0.47	0.7	0.18	0.36	0.58	0.6	0.89	0.48	-0.09	0.65	0.02	0.7
Cash	0.18	0.04	0.23	0.26	0.15	0.24	-0.06	0.24		0.1	-0.22	0.18	0.37	0.31	0.03	0.21	-0.07	0.38	0.16	0.28	0.31	0.38	-0.36	0.05	-0.22	0.11
Non Current Assets Total	0.91	0.89	0.58	0.9	0.94	0.9	0.88	0.83	0.1		0.22	0.24	0.74	0.4	0.85	0.86	0.36	0.01	0.9	0.78	0.74	0.72	0.13	0.93	-0.05	0.92
Non Currrent Assets Other	0.22	0.14	0.28	0.17	0.3	0.12	0.16	0.18	-0.22	0.22		0.77	0.18	0.3	0.29	0.1	0.27	0.13	0.23	0.4	0.31	0.4	0.82	0.15	0.15	-0.05
Cash And Short Term Investments	0.4	0.3	0.38	0.37	0.27	0.31	0.28	0.1	0.18	0.24	0.77		0.37	0.02	0.47	0.28	0.3	-0.11	0.42	0.62	0.25	0.65	0.85	0.25	0.29	0.02
Net Receivables	0.87	0.77	0.54	0.87	0.72	0.85	0.73	0.59	0.37	0.74	0.18	0.37		0.11	0.8	0.85	0.46	-0.1	0.86	0.9	0.55	0.89	0.16	0.77	-0.05	0.69
Common Stock Shares Outstanding	0.2	0.04	0.22	0.2	0.53	0.21	0.01	0.67	0.31	0.4	0.3	0.02	0.11		0.01	0.17	-0.21	0.81	0.12	0.15	0.69	0.16	-0.19	0.21	-0.12	0.27
Non Current Liabilities Total	0.93	0.97	0.66	0.92	0.7	0.87	0.97	0.47	0.03	0.85	0.29	0.47	0.8	0.01		0.82	0.44	-0.31	0.98	0.86	0.43	0.85	0.42	0.93	0.03	0.8
Inventory	0.95	0.85	0.68	0.94	0.85	0.98	0.83	0.7	0.21	0.86	0.1	0.28	0.85	0.17	0.82		0.55	-0.23	0.91	0.91	0.53	0.78	0.15	0.88	0.04	0.84
Other Current Assets	0.45	0.42	0.57	0.43	0.36	0.48	0.43	0.18	-0.07	0.36	0.27	0.3	0.46	-0.21	0.44	0.55		-0.49	0.45	0.51	-0.09	0.5	0.32	0.35	-0.19	0.28
Other Stockholder Equity	-0.21	-0.31	-0.06	-0.19	0.15	-0.21	-0.35	0.36	0.38	0.01	0.13	-0.11	-0.1	0.81	-0.31	-0.23	-0.49		-0.25	-0.18	0.48	-0.11	-0.37	-0.2	-0.1	-0.11
Total Liab	0.98	0.98	0.67	0.99	0.78	0.95	0.96	0.58	0.16	0.9	0.23	0.42	0.86	0.12	0.98	0.91	0.45	-0.25		0.91	0.53	0.87	0.31	0.96	-0.02	0.88
Total Current Assets	0.93	0.81	0.68	0.91	0.79	0.91	0.78	0.6	0.28	0.78	0.4	0.62	0.9	0.15	0.86	0.91	0.51	-0.18	0.91		0.56	0.93	0.43	0.8	0.1	0.67
Common Stock	0.59	0.44	0.14	0.58	0.83	0.57	0.41	0.89	0.31	0.74	0.31	0.25	0.55	0.69	0.43	0.53	-0.09	0.48	0.53	0.56		0.49	0.02	0.57	0.04	0.61
Accounts Payable	0.85	0.77	0.7	0.85	0.68	0.81	0.73	0.48	0.38	0.72	0.4	0.65	0.89	0.16	0.85	0.78	0.5	-0.11	0.87	0.93	0.49		0.41	0.74	0.01	0.58
Short Term Investments	0.28	0.26	0.24	0.21	0.13	0.17	0.3	-0.09	-0.36	0.13	0.82	0.85	0.16	-0.19	0.42	0.15	0.32	-0.37	0.31	0.43	0.02	0.41		0.21	0.4	-0.05
Intangible Assets	0.96	0.97	0.57	0.96	0.81	0.92	0.96	0.65	0.05	0.93	0.15	0.25	0.77	0.21	0.93	0.88	0.35	-0.2	0.96	0.8	0.57	0.74	0.21		0.01	0.95
Current Deferred Revenue	0.02	-0.04	-0.14	-0.05	0.03	-0.04	-0.01	0.02	-0.22	-0.05	0.15	0.29	-0.05	-0.12	0.03	0.04	-0.19	-0.1	-0.02	0.1	0.04	0.01	0.4	0.01		-0.13
Short Term Debt	0.88	0.91	0.47	0.9	0.8	0.88	0.89	0.7	0.11	0.92	-0.05	0.02	0.69	0.27	0.8	0.84	0.28	-0.11	0.88	0.67	0.61	0.58	-0.05	0.95	-0.13

Click cells to compare fundamentals

Torrent Pharmaceuticals Account Relationship Matchups

Torrent Pharmaceuticals fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	140.4B	140.7B	131.0B	150.1B	150.6B	81.8B
Short Long Term Debt Total	58.4B	48.7B	40.7B	53.7B	40.2B	27.1B
Other Current Liab	8.1B	8.0B	7.4B	1.0B	8.1B	4.9B
Total Current Liabilities	54.8B	48.9B	44.2B	54.5B	54.3B	29.4B
Total Stockholder Equity	48.2B	58.4B	59.5B	62.0B	68.6B	72.0B
Property Plant And Equipment Net	35.3B	36.3B	32.5B	34.6B	35.8B	20.1B
Net Debt	51.8B	43.0B	36.7B	48.6B	31.9B	22.3B
Retained Earnings	18.9B	28.1B	29.2B	33.0B	39.4B	41.4B
Cash	6.6B	5.7B	4.0B	5.1B	8.4B	4.8B
Non Current Assets Total	90.3B	85.5B	79.3B	97.0B	94.5B	99.2B
Non Currrent Assets Other	2.6B	1.1B	3.2B	2.0B	9.0B	9.5B
Cash And Short Term Investments	6.6B	7.4B	5.8B	8.4B	10.0B	8.0B
Net Receivables	20.0B	18.9B	19.2B	19.5B	18.4B	12.3B
Liabilities And Stockholders Equity	140.4B	140.7B	131.0B	150.1B	150.6B	81.8B
Non Current Liabilities Total	37.3B	33.5B	27.3B	33.7B	27.8B	20.6B
Inventory	21.5B	26.8B	24.6B	22.3B	22.8B	13.3B
Other Current Assets	21.7B	21.0B	21.2B	3.0B	4.8B	8.4B
Total Liab	92.1B	82.4B	71.5B	88.1B	82.0B	50.0B
Total Current Assets	50.1B	55.2B	51.6B	53.1B	56.1B	35.6B
Accumulated Other Comprehensive Income	(12.4B)	29.4B	29.5B	27.3B	27.4B	28.8B
Accounts Payable	20.5B	20.7B	16.7B	16.8B	20.9B	15.0B
Short Term Investments	5M	1.7B	1.8B	3.3B	1.7B	1.6B
Intangible Assets	43.7B	39.8B	35.5B	50.9B	45.8B	23.9B
Current Deferred Revenue	(25.4B)	7.9B	7.3B	8.5B	45M	42.8M
Short Term Debt	25.5B	19.7B	19.5B	28.2B	23.5B	15.5B
Other Liab	3.2B	4.3B	3.8B	5.7B	6.6B	4.2B
Net Tangible Assets	(3.6B)	1.1B	15.1B	21.5B	19.3B	20.3B
Other Assets	6.9B	5.3B	6.8B	5.4B	6.3B	3.9B
Long Term Debt	32.8B	29.4B	21.2B	25.0B	16.0B	27.5B
Short Long Term Debt	25.1B	7.0B	19.0B	28.0B	23.3B	16.9B
Property Plant Equipment	35.3B	36.3B	32.5B	34.6B	39.8B	30.0B
Good Will	3.4B	3.4B	2.6B	3.4B	3.4B	3.0B
Long Term Debt Total	33.0B	29.6B	21.6B	25.5B	29.3B	31.8B
Non Current Liabilities Other	600K	50M	40M	20M	10M	9.5M
Cash And Equivalents	2.6B	149.3M	228.1M	379.8M	341.8M	324.7M
Net Invested Capital	106.1B	65.4B	99.7B	115.0B	107.9B	81.4B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

Other Information on Investing in Torrent Stock

Balance Sheet is a snapshot of the financial position of Torrent Pharmaceuticals at a specified time, usually calculated after every quarter, six months, or one year. Torrent Pharmaceuticals Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Torrent Pharmaceuticals and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Torrent currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Torrent Cash And Short Term Investments vs Non Current Assets Total Analysis

Cash And Short Term Investments vs Non Current Assets Total

Cash And Short Term Investments vs Non Current Assets Total Correlation Analysis

Correlation Coefficient

Cash And Short Term Investments

Non Current Assets Total

Torrent Pharmaceuticals fundamental ratios Correlations

Torrent Pharmaceuticals Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Torrent Pharmaceuticals fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in Torrent Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Liabilities	+ 0.99	Total Assets
Net Debt	+ 0.99	Short Long Term Debt Total
Total Liab	+ 0.99	Total Current Liabilities
Property Plant And Equipment Net	+ 0.98	Total Assets
Total Liab	+ 0.98	Total Assets
Total Liab	+ 0.98	Short Long Term Debt Total

Other Stockholder Equity	- 0.49	Other Current Assets
Short Term Investments	- 0.37	Other Stockholder Equity
Short Term Investments	- 0.36	Cash
Other Stockholder Equity	- 0.35	Net Debt
Other Stockholder Equity	- 0.31	Non Current Liabilities Total
Other Stockholder Equity	- 0.31	Short Long Term Debt Total